21 CFR 520.2260c
§ 520.2260c Sulfamethazine sustained-release tablets.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.2260c, § 520.2260c Sulfamethazine sustained-release tablets, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87332
- Permanent ID
ys:prov:87332@1- SHA-256
1e3a215e9d7e1042bc32e0f721e4754cef6ac7bae5b01abb53e27092394ab182
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each extended-release tablet contains 8 grams sulfamethazine.
(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Related tolerances. See § 556.670 of this chapter.
(d) Conditions of use—(1) Amount. 8 grams (1 tablet) per 45 pounds of body weight as a single dose.
(2) Indications for use. In calves for sustained treatment of pneumonia caused by Pasteurella spp., colibacillosis (bacterial scours) caused by Escherichia coli; and calf diptheria caused by Fusobacterium necrophorum.
(3) Limitations. Treated animals must not be slaughtered for food within 18 days after the latest treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.